Comparison between the biochemical properties of plasma chitotriosidase from normal individuals and from patients with Gaucher disease, GM1-gangliosidosis, Krabbe disease and heterozygotes for Gaucher disease

被引:22
|
作者
Wajner, Alessandro
Michelin, Kristiane
Burin, Maira G.
Pires, Ricardo F.
Pereira, Maria Luiza S.
Giugliani, Roberto
Coelho, Janice C. [1 ]
机构
[1] Univ Fed Rio Grande do Sul, ICBS, Dept Bioquim, Porto Alegre, RS, Brazil
[2] Hosp Clin Porto Alegre, Serv Genet Med, Porto Alegre, RS, Brazil
[3] Univ Fed Rio Grande do Sul, Dept Genet IB, Porto Alegre, RS, Brazil
关键词
chitotriosidase; Gaucher disease; GM1-gangliosidosis; Krabbe disease; enzyme kinetics; lysosomal storage diseases;
D O I
10.1016/j.clinbiochem.2006.12.003
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives: The aim of the present work was to establish the range of chitotriosidase (CT) activity in normal individuals (controls), patients with Gaucher disease (GD), GM1-gangliosidosis (GM1), Krabbe disease (KD) and heterozygotes for Gaucher disease (HG). The kinetics of the enzyme in the five groups was also investigated. Design and methods: Plasma CT activity, as well as K-m, V-max, optimum pH and thermal stability of the enzyme was determined in plasma of controls, GM I, KD, GD and HG subjects. Results: CT activity in GD, GM1 and KD patients was, respectively, around 600-fold, 15-fold and 12-fold greater than in normal individuals. There was no significant difference between CT activity in the HG and the control group. We also demonstrated that all CT kinetic parameters evaluated (optimum pH, K-m, thermal stability) in plasma of GD, KD and GM1 patients were significantly different from those of normal individuals. Regarding to thermal stability, our results show that CT activity in the Control group was more stable than in the other groups. Conclusions: Based on the differences found in the biochemical parameters studied, we presume that the parameters analyzed may be useful in the diagnosis of the Lysosomal Storage Diseases. (c) 2007 Published by The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:365 / 369
页数:5
相关论文
共 50 条
  • [41] Plasma chitotriosidase activity in Argentinean patients with Gaucher disease, various lysosomal enzymopathies and other inherited metabolic disorders
    de Kremer, RD
    de Capra, AP
    Angaroni, CJ
    de Ayala, AG
    MEDICINA-BUENOS AIRES, 1997, 57 (06) : 677 - 684
  • [42] Development of a plasma lyso-Gb1 clinical assay and its application to Gaucher and Krabbe disease patient plasma
    Heywood, Wendy E.
    Spiewak, Justyna
    Doykov, Ivan
    Burke, Derek
    Heales, Simon
    Mills, Kevin
    MOLECULAR GENETICS AND METABOLISM, 2020, 129 (02) : S73 - S73
  • [43] Risk Factors For Developing Avascular Necrosis Or Fractures In Patients With Type 1 Gaucher Disease: Analysis From The Gaucher Registry
    Khan, Aneal
    Hangartner, Thomas
    Weinreb, Neal
    Taylor, John
    Mistry, Pramod
    MOLECULAR GENETICS AND METABOLISM, 2012, 105 (02) : S39 - S40
  • [44] Untreated patients with type 1 Gaucher disease: Who are they? Preliminary results from the Gaucher non-treated study
    Serratrice, Christine
    Stirnemann, Jerome
    Berrahal, Amina
    Bengherbia, Monia
    Belmatoug, Nadia
    Camou, Fabrice
    Berger, Marc
    MOLECULAR GENETICS AND METABOLISM, 2018, 123 (02) : S128 - S129
  • [45] BIOCHEMICAL AND MORPHOLOGICAL ANALYSIS OF A CORNEAL BUTTON FROM A GAUCHER DISEASE CARRIER WITH KERATOCONUS
    SILVAARAUJO, A
    TAVARES, MA
    LEMOS, MM
    SAMIRANDA, MC
    ABREUDIAS, P
    SALGADOBORGES, J
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1994, 35 (04) : 1604 - 1604
  • [46] A natural history study of pediatric patients with early onset of GM1 gangliosidosis, GM2 gangliosidoses, or gaucher disease type 2 (RETRIEVE)
    Heron, Benedicte
    Batzios, Spyros
    Mengel, Eugen
    Giugliani, Roberto
    Patterson, Marc
    Gautschi, Matthias
    Cornelisse, Peter
    Trokan, Luba
    Schwierin, Barbara
    Rohrbach, Marianne
    ORPHANET JOURNAL OF RARE DISEASES, 2024, 19 (01)
  • [47] Characteristics of 27 patients with type 3 Gaucher disease: a descriptive analysis from the Gaucher Outcome Survey
    Schwartz, Ida Vanessa D.
    Goker-Alpan, Ozlem
    Kishnani, Priya
    Zimran, Ari
    Renault, Lydie
    Panahloo, Zoya
    Deegan, Patrick
    MOLECULAR GENETICS AND METABOLISM, 2017, 120 (1-2) : S120 - S121
  • [48] Gaucher disease type 3 patient journey: Results from interviews with neuronopathic Gaucher disease patients highlight the challenges of diagnosis and care
    Refaei, Laith
    Sekulic, Davorka
    Doerr, Andrew
    McCrone, Julia
    Gould, Rebecca
    Batsu, Isabela
    MOLECULAR GENETICS AND METABOLISM, 2023, 138 (02) : 110 - 110
  • [49] Medical histories in Gaucher disease: a descriptive analysis from 852 patients in the Gaucher Outcome Survey (GOS)
    Elstein, Deborah
    Belmatoug, Nadia
    Giraldo, Pilar
    Lau, Heather
    Lukina, Elena
    Panahloo, Zoya
    Zimran, Ari
    MOLECULAR GENETICS AND METABOLISM, 2017, 120 (1-2) : S45 - S45
  • [50] Characteristics of 26 patients with type 3 Gaucher disease: A descriptive analysis from the Gaucher Outcome Survey
    Schwartz, Ida Vanessa D.
    Goker-Alpan, Ozlem
    Kishnani, Priya S.
    Zimran, Ari
    Renault, Lydie
    Panahloo, Zoya
    Deegan, Patrick
    MOLECULAR GENETICS AND METABOLISM REPORTS, 2018, 14 : 73 - 79